Aravax
Early stage biotechnology company focused on developing the first safe and rapidly effective treatment for peanut allergy. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
AUD260—389m (Dealroom.co estimates Feb 2024.)
Melbourne Victoria (HQ)
Authorizing premium user...